Selected research
Industry Growth & Trends
Global Primaquine Phosphate Tablets Industry Growth and Trends Forecast to 2032
Market perspective
The global Primaquine Phosphate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Primaquine Phosphate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Primaquine Phosphate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Primaquine Phosphate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Primaquine Phosphate Tablets include Chongqing Kerui Pharmaceutical, Shandong Xinhua Pharmaceutical, Southwest Pharmaceutical, Shanghai Pharmaceuticals, Sanofi, Chengdu Diao Pharmaceutical Group and Teva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Primaquine Phosphate Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Primaquine Phosphate Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Primaquine Phosphate Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Primaquine Phosphate Tablets.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Primaquine Phosphate Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Primaquine Phosphate Tablets Market by Company
Chongqing Kerui Pharmaceutical
Shandong Xinhua Pharmaceutical
Southwest Pharmaceutical
Shanghai Pharmaceuticals
Sanofi
Chengdu Diao Pharmaceutical Group
Teva Pharmaceuticals
Primaquine Phosphate Tablets Segment by Type
Original Drug
Generic Drug
Primaquine Phosphate Tablets Segment by Application
Hospital
Clinic
Others
Primaquine Phosphate Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primaquine Phosphate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Primaquine Phosphate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primaquine Phosphate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Primaquine Phosphate Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Primaquine Phosphate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital
- Clinic
- Others
Companies covered
- Chongqing Kerui Pharmaceutical
- Shandong Xinhua Pharmaceutical
- Southwest Pharmaceutical
- Shanghai Pharmaceuticals
- Sanofi
- Chengdu Diao Pharmaceutical Group
- Teva Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Primaquine Phosphate Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Primaquine Phosphate Tablets Sales Estimates and Forecasts (2021-2032)
- 1.3 Primaquine Phosphate Tablets Market by Type
- 1.3.1 Original Drug
- 1.3.2 Generic Drug
- 1.4 Global Primaquine Phosphate Tablets Market Size by Type
- 1.4.1 Global Primaquine Phosphate Tablets Market Size Overview by Type (2021-2032)
- 1.4.2 Global Primaquine Phosphate Tablets Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Primaquine Phosphate Tablets Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Primaquine Phosphate Tablets Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Primaquine Phosphate Tablets Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Primaquine Phosphate Tablets Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Primaquine Phosphate Tablets Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Primaquine Phosphate Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Primaquine Phosphate Tablets Industry Trends
- 2.2 Primaquine Phosphate Tablets Industry Drivers
- 2.3 Primaquine Phosphate Tablets Industry Opportunities and Challenges
- 2.4 Primaquine Phosphate Tablets Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Primaquine Phosphate Tablets Revenue (2021-2026)
- 3.2 Global Top Players by Primaquine Phosphate Tablets Sales (2021-2026)
- 3.3 Global Top Players by Primaquine Phosphate Tablets Price (2021-2026)
- 3.4 Global Primaquine Phosphate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Primaquine Phosphate Tablets Major Company Production Sites & Headquarters
- 3.6 Global Primaquine Phosphate Tablets Company, Product Type & Application
- 3.7 Global Primaquine Phosphate Tablets Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Primaquine Phosphate Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Primaquine Phosphate Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Primaquine Phosphate Tablets Tier 1, Tier 2, and Tier 3
4 Primaquine Phosphate Tablets Regional Status and Outlook
- 4.1 Global Primaquine Phosphate Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Primaquine Phosphate Tablets Historic Market Size by Region
- 4.2.1 Global Primaquine Phosphate Tablets Sales in Volume by Region (2021-2026)
- 4.2.2 Global Primaquine Phosphate Tablets Sales in Value by Region (2021-2026)
- 4.2.3 Global Primaquine Phosphate Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Primaquine Phosphate Tablets Forecasted Market Size by Region
- 4.3.1 Global Primaquine Phosphate Tablets Sales in Volume by Region (2027-2032)
- 4.3.2 Global Primaquine Phosphate Tablets Sales in Value by Region (2027-2032)
- 4.3.3 Global Primaquine Phosphate Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Primaquine Phosphate Tablets by Application
- 5.1 Primaquine Phosphate Tablets Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Primaquine Phosphate Tablets Market Size by Application
- 5.2.1 Global Primaquine Phosphate Tablets Market Size Overview by Application (2021-2032)
- 5.2.2 Global Primaquine Phosphate Tablets Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Primaquine Phosphate Tablets Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Primaquine Phosphate Tablets Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Primaquine Phosphate Tablets Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Primaquine Phosphate Tablets Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Primaquine Phosphate Tablets Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Primaquine Phosphate Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Chongqing Kerui Pharmaceutical
- 6.1.1 Chongqing Kerui Pharmaceutical Company Information
- 6.1.2 Chongqing Kerui Pharmaceutical Business Overview
- 6.1.3 Chongqing Kerui Pharmaceutical Primaquine Phosphate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Chongqing Kerui Pharmaceutical Primaquine Phosphate Tablets Product Portfolio
- 6.1.5 Chongqing Kerui Pharmaceutical Recent Developments
- 6.2 Shandong Xinhua Pharmaceutical
- 6.2.1 Shandong Xinhua Pharmaceutical Company Information
- 6.2.2 Shandong Xinhua Pharmaceutical Business Overview
- 6.2.3 Shandong Xinhua Pharmaceutical Primaquine Phosphate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shandong Xinhua Pharmaceutical Primaquine Phosphate Tablets Product Portfolio
- 6.2.5 Shandong Xinhua Pharmaceutical Recent Developments
- 6.3 Southwest Pharmaceutical
- 6.3.1 Southwest Pharmaceutical Company Information
- 6.3.2 Southwest Pharmaceutical Business Overview
- 6.3.3 Southwest Pharmaceutical Primaquine Phosphate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Southwest Pharmaceutical Primaquine Phosphate Tablets Product Portfolio
- 6.3.5 Southwest Pharmaceutical Recent Developments
- 6.4 Shanghai Pharmaceuticals
- 6.4.1 Shanghai Pharmaceuticals Company Information
- 6.4.2 Shanghai Pharmaceuticals Business Overview
- 6.4.3 Shanghai Pharmaceuticals Primaquine Phosphate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Shanghai Pharmaceuticals Primaquine Phosphate Tablets Product Portfolio
- 6.4.5 Shanghai Pharmaceuticals Recent Developments
- 6.5 Sanofi
- 6.5.1 Sanofi Company Information
- 6.5.2 Sanofi Business Overview
- 6.5.3 Sanofi Primaquine Phosphate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sanofi Primaquine Phosphate Tablets Product Portfolio
- 6.5.5 Sanofi Recent Developments
- 6.6 Chengdu Diao Pharmaceutical Group
- 6.6.1 Chengdu Diao Pharmaceutical Group Company Information
- 6.6.2 Chengdu Diao Pharmaceutical Group Business Overview
- 6.6.3 Chengdu Diao Pharmaceutical Group Primaquine Phosphate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Chengdu Diao Pharmaceutical Group Primaquine Phosphate Tablets Product Portfolio
- 6.6.5 Chengdu Diao Pharmaceutical Group Recent Developments
- 6.7 Teva Pharmaceuticals
- 6.7.1 Teva Pharmaceuticals Company Information
- 6.7.2 Teva Pharmaceuticals Business Overview
- 6.7.3 Teva Pharmaceuticals Primaquine Phosphate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Teva Pharmaceuticals Primaquine Phosphate Tablets Product Portfolio
- 6.7.5 Teva Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Primaquine Phosphate Tablets Sales by Country
- 7.1.1 North America Primaquine Phosphate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Primaquine Phosphate Tablets Sales by Country (2021-2026)
- 7.1.3 North America Primaquine Phosphate Tablets Sales Forecast by Country (2027-2032)
- 7.2 North America Primaquine Phosphate Tablets Market Size by Country
- 7.2.1 North America Primaquine Phosphate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Primaquine Phosphate Tablets Market Size by Country (2021-2026)
- 7.2.3 North America Primaquine Phosphate Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Primaquine Phosphate Tablets Sales by Country
- 8.1.1 Europe Primaquine Phosphate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Primaquine Phosphate Tablets Sales by Country (2021-2026)
- 8.1.3 Europe Primaquine Phosphate Tablets Sales Forecast by Country (2027-2032)
- 8.2 Europe Primaquine Phosphate Tablets Market Size by Country
- 8.2.1 Europe Primaquine Phosphate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Primaquine Phosphate Tablets Market Size by Country (2021-2026)
- 8.2.3 Europe Primaquine Phosphate Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Primaquine Phosphate Tablets Sales by Country
- 9.1.1 Asia-Pacific Primaquine Phosphate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Primaquine Phosphate Tablets Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Primaquine Phosphate Tablets Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Primaquine Phosphate Tablets Market Size by Country
- 9.2.1 Asia-Pacific Primaquine Phosphate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Primaquine Phosphate Tablets Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Primaquine Phosphate Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Primaquine Phosphate Tablets Sales by Country
- 10.1.1 South America Primaquine Phosphate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Primaquine Phosphate Tablets Sales by Country (2021-2026)
- 10.1.3 South America Primaquine Phosphate Tablets Sales Forecast by Country (2027-2032)
- 10.2 South America Primaquine Phosphate Tablets Market Size by Country
- 10.2.1 South America Primaquine Phosphate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Primaquine Phosphate Tablets Market Size by Country (2021-2026)
- 10.2.3 South America Primaquine Phosphate Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Primaquine Phosphate Tablets Sales by Country
- 11.1.1 Middle East and Africa Primaquine Phosphate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Primaquine Phosphate Tablets Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Primaquine Phosphate Tablets Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Primaquine Phosphate Tablets Market Size by Country
- 11.2.1 Middle East and Africa Primaquine Phosphate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Primaquine Phosphate Tablets Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Primaquine Phosphate Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Primaquine Phosphate Tablets Value Chain Analysis
- 12.1.1 Primaquine Phosphate Tablets Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Primaquine Phosphate Tablets Production Mode & Process
- 12.2 Primaquine Phosphate Tablets Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Primaquine Phosphate Tablets Distributors
- 12.2.3 Primaquine Phosphate Tablets Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst